Relevance of PD-L1 non-coding polymorphisms on the prognosis of a genetically admixed NSCLC cohort (2021)
- Authors:
- USP affiliated authors: FABRO, ALEXANDRE TODOROVIC - FMRP ; TAKAGAKI, TERESA YAE - FM ; NAGAI, MARIA APARECIDA - FM ; CAPELOZZI, VERA LUIZA - FM ; RUGOLO, JULIANA MACHADO - FM ; BALDAVIRA, CAMILA MACHADO - FM
- Unidades: FMRP; FM
- DOI: 10.2147/PGPM.S286717
- Subjects: SEQUENCIAMENTO GENÉTICO; NEOPLASIAS PULMONARES; POLIMORFISMO
- Keywords: Non-small cell lung cancer; Single nucleotide polymorphisms; Nextgeneration sequencing
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Macclesfield
- Date published: 2021
- Source:
- Título: Pharmacogenomics and Personalized Medicine
- ISSN: 1178-7066
- Volume/Número/Paginação/Ano: v. 14, p. 239-252, 2021
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by-nc
-
ABNT
MACHADO-RUGOLO, Juliana et al. Relevance of PD-L1 non-coding polymorphisms on the prognosis of a genetically admixed NSCLC cohort. Pharmacogenomics and Personalized Medicine, v. 14, p. 239-252, 2021Tradução . . Disponível em: https://doi.org/10.2147/PGPM.S286717. Acesso em: 28 dez. 2025. -
APA
Machado-Rugolo, J., Prieto, T. G., Fabro, A. T., Cuentas, E. R. P., Sá, V. K. de, Baldavira, C. M., et al. (2021). Relevance of PD-L1 non-coding polymorphisms on the prognosis of a genetically admixed NSCLC cohort. Pharmacogenomics and Personalized Medicine, 14, 239-252. doi:10.2147/PGPM.S286717 -
NLM
Machado-Rugolo J, Prieto TG, Fabro AT, Cuentas ERP, Sá VK de, Baldavira CM, Rainho CA, Castelli E da C, Farhat C, Takagaki TY, Nagai MA, Capelozzi VL. Relevance of PD-L1 non-coding polymorphisms on the prognosis of a genetically admixed NSCLC cohort [Internet]. Pharmacogenomics and Personalized Medicine. 2021 ; 14 239-252.[citado 2025 dez. 28 ] Available from: https://doi.org/10.2147/PGPM.S286717 -
Vancouver
Machado-Rugolo J, Prieto TG, Fabro AT, Cuentas ERP, Sá VK de, Baldavira CM, Rainho CA, Castelli E da C, Farhat C, Takagaki TY, Nagai MA, Capelozzi VL. Relevance of PD-L1 non-coding polymorphisms on the prognosis of a genetically admixed NSCLC cohort [Internet]. Pharmacogenomics and Personalized Medicine. 2021 ; 14 239-252.[citado 2025 dez. 28 ] Available from: https://doi.org/10.2147/PGPM.S286717 - Clinical outcome of Brazilian patients with non-small cell lung cancer in early stage harboring rare mutations in epidermal growth factor receptor
- Variants in epithelial-mesenchymal transition and immune checkpoint genes are associated with immune cell profiles and predict survival in non–small cell lung cancer
- Clinical relevant oncogenic drivers in advanced adenocarcinoma discloses new therapeutic target in negative EGFR/ALK/KRAS patients
- Circulating plasma miRNA and clinical/hemodynamic characteristics provide additional predictive information about acute pulmonary thromboembolism, chronic thromboembolic pulmonary hypertension and idiopathic pulmonary hypertension
- Usefulness of complementary next-generation sequencing and quantitative immunohistochemistry panels for predicting brain metastases and selecting treatment outcomes of non-small cell lung cancer
- PI4K2A. [Editorial]: a novel potential therapeutic target for lung cancer
- Mutation profile and protein expression for predictive testing in lung adenocarcinoma: a study of 200 patients from Brazil
- Next-generation sequencing of non-small cell lung cancer using a customized, targeted sequencing panel: focus on epithelial-mesenchymal transition
- Interobserver agreement of usual interstitial pneumonia diagnosis correlated with patient outcome
- Estudo do efeito da beta 2-glicoproteína I no desenvolvimento da rede vascular de membrana corioalantóica de embriões de galinha
Informações sobre o DOI: 10.2147/PGPM.S286717 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003234857.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
